Frazier Management LLC Bicycle Therapeutics PLC Transaction History

Frazier Management LLC

  • $0
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$40.12 - $59.5 $22.3 Million - $33 Million
-555,240 Closed
0 $0
Q4 2021

Feb 08, 2022
BUY
$41.7 - $61.14 $4.69 Million - $6.87 Million
112,360 Added 25.37%
555,240 $33.8 Million
Q3 2021

Nov 12, 2021
BUY
$27.95 - $44.24 $12.4 Million - $19.6 Million
442,880 New
442,880 $18.4 Million

Others Institutions Holding BCYC

# of Institutions
111
Shares Held
40.8M
Call Options Held
39.6K
Put Options Held
24.6K
View Full List

About BICYCLE THERAPEUTICS plc

BCYC Quotes by TradingView
  • Ticker BCYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,676,100
  • Market Cap $436M
  • Description
  • Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...
More about BCYC
Track This Portfolio

Track Frazier Management LLC Portfolio

Follow Frazier Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frazier Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email